ATM is considered as a tumour suppressor and patients with Ataxia telangiectasia (with homozygous ATM mutation) have extreme radiosensitivity, immunological deficiencies, neurodegeneration and cancer predisposition [17]. This evidence concerns the gene ATM and Ataxia-telangiectasia.